Xeris Biopharma appointed Nerissa Kreher as a director effective July 1, 2026, and named John Shannon as Chair with Marla S. Persky designated Lead Independent Director.
| IndividualNerissa Kreher, M.D.John ShannonMarla S. Persky | RoleClass III DirectorChairperson of the BoardLead Independent Director | Type of ChangeAppointedAppointedDesignated | Effective DateJuly 1, 2026July 1, 2026July 1, 2026 | ReasonBoard increased size from seven to eight creating vacancy; appointment to fill vacancyBoard leadership changeBoard leadership change | Replacement InfoNot disclosedNot disclosedNot disclosed | Background DetailsChief Medical Officer of Alltrna since Jan 2025; founder of Mountainview Clinical Development Consulting since Jul 2024; prior CMO roles at Entrada, Tiburio, AVROBIO; MD, MS, Executive MBA, BSServes as the Company’s Chief Executive OfficerNot disclosed | Board/Committee Role ChangesNot appointed to any committees at this timeNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.